World Covid-19. Reports against Didier Raoult's clinical studies classified without follow-up

© AFP The studies concerned hydroxychloroquine against Covid-19. (Illustration)

The two reports concerning clinical studies on hydroxychloroquine against Covid-19 carried out by the IHU Méditerranée Infection de Marseille (Bouches-du-Rhône) and Didier Raoult were dismissed by the public prosecutor from the city. A health professional made these reports last April. They concerned the conditions under which the studies were carried out.

The public prosecutor of Marseille ( Bouches-du-Rhône ) dismissed the two reports concerning the clinical trial on hydroxychloroquine carried out on patients affected by Covid-19 . This is what the prosecution reports in a press release, published Tuesday, November 24, and relayed by France 3 Provence Alpes Côte d'Azur . The study was conducted by the IHU Méditerranée Infection in Marseille, led by Prof. Didier Raoult.

Who will will partner Kylian Mbappe for France at Euro 2020?

The France boss has added firepower to his attacking arsenal - as opposed to having lost it - since the 2018 World Cup victory in Russia, but has a few dilemmas with stars out of form.The France boss has added rather than lost firepower to his attacking arsenal since the 2018 World Cup victory in Russia, while seasoned internationals Antoine Griezmann and Olivier Giroud are still key members of his squad.

Objective: To describe the clinical characteristics and outcomes of patients with COVID - 19 Design, setting, and participants: Case series of patients with COVID - 19 admitted to 12 hospitals in New Outcomes were assessed for 2634 patients who were discharged or had died at the study end point.

Professor Raoult is an infectious diseases specialist and head of the IHU Méditerranée Infection, who has He said that the first Covid - 19 patients he had treated with the drug chloroquine had seen a rapid and Researchers worldwide are continuing to work on developing a vaccine against Covid - 19 .

It was a health professional who made these reports last April to the prosecutor's office, La Provence recalled last week. They concerned the conditions under which the studies were carried out. He pointed to the alleged violations, believing that they fell outside the legal and regulatory framework in force. If this had been the case, according to the prosecution, they could have been considered as criminal offenses, note 20 Minutes . However, "it appears that the offenses relating to the facts reported in the denunciation are insufficiently characterized" according to the magistrate, cited by our colleagues.

The prosecution notably stressed that at the time of the facts, no drug was officially authorized to treat Covid-19 or prevent infection. Doctors were then entitled to prescribe drugs to patients, even if they went beyond their indication approved by their marketing authorization.

Pfizer’s Covid-19 vaccine just came a little closer to emergency approval

Pfizer and BioNTech now say their vaccine is 95 percent effective and has cleared its trial benchmarks.A press release out Wednesday from the two companies reports the results of 170 Covid-19 cases confirmed in their clinical trial pool: Eight in the group that received the vaccine got Covid-19 versus 162 in the placebo group, demonstrating an efficacy of 95 percent.

Background: The 2019 coronavirus disease ( COVID - 19 ) epidemic is a public health emergency of international concern and poses a challenge to The aim of this study was to survey the general public in China to better understand their levels of psychological impact, anxiety, depression, and

Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease ( COVID - 19 ). Among patients in multiple early studies from Wuhan, China who had severe COVID - 19 illness, the median time from their onset of illness to the time they experienced dyspnea was 5–8 days

And this, by virtue of the freedom of prescription of doctors, note France 3. Didier Raoult is also the subject of another complaint in connection with hydroxychloroquine. The French-language Infectious Pathology Society (Spilf) accuses him of having promoted it when its effectiveness was not proven and considers that he violated the code of medical ethics.

For his part, the Marseille professor is also increasing the complaints against his colleagues, specifies La Provence : “In the viewfinder, a vice-president of the Departmental Order of Physicians and Prof. Karine Lacombe, head of the infectious diseases department at Saint-Antoine hospital in Paris ”, writes the regional daily.